Varian Medical Systems Inc. (VAR) Falls 2.62% for February 11

Equities Staff |

One of the S&P 500’s big losers for Thursday February 11 was Varian Medical Systems Inc. (VAR). The company’s stock fell 2.62% to $75.11 on volume of 492,381 shares.

The stock opened the day at 75.83 and traded between a low of $74.56 and a high of $76.89. The stock finished the day down $2.02 per share. Varian Medical Systems Inc. has an average daily volume of 871,026 and a total float of 96.88 million shares. The 50-day SMA for Varian Medical Systems Inc. is $77.96 and its 200-day SMA is $81.73. The high for the stock over the last 52 weeks is $96.67 and the low is $71.07.

Varian Medical Systems Inc manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Varian Medical Systems Inc. is centered in Palo Alto, CA, and has 7,300 employees. Today’s trading day leaves the company with a market cap of $7.28 billion. The company has a P/S ratio of n/a, P/B ratio of 4.41, and a 26.7.

For a complete fundamental analysis analysis of Varian Medical Systems Inc., check out’s Stock Valuation Analysis report for VAR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

AfterMaster Inc

Studio One Media Inc is a diversified media and technology company. It is engaged in the development and commercialization of proprietary, edge audio and video technologies for professional and consumer…

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…